1 results match your criteria: "Department of Nuclear Medicine of Hebei General Hospital[Affiliation]"
Immunobiology
March 2024
Department of Nuclear Medicine of Hebei General Hospital, Shijiazhuang 050051, Hebei province, China.
Objective: The value of novel biomarkers for DKD has received increasing attention, and there is an urgent need for novel biomarkers with sensitivity, specificity and ability to detect kidney damage.miR-377 regulates many basic biological processes, plays a key role in tumor cell proliferation, migration and inflammation, and can also increase the expression of matrix proteins and fibronectin, leading to renal tubulointerstitial inflammation and renal fibrosis. Lipoprotein-associated phospholipase A2, as an inflammatory marker, is involved in the pathological process of microalbuminuria production and renal function decline, and is a predictive factor of microalbuminuria production and renal function decline, and can be used as an indicator to evaluate the progression of DKD.
View Article and Find Full Text PDF